Lejeune, M.; Duray, E.; Peipp, M.; Clémenceau, B.; Baron, F.; Beguin, Y.; Caers, J.
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers 2021, 13, 3072.
https://doi.org/10.3390/cancers13123072
AMA Style
Lejeune M, Duray E, Peipp M, Clémenceau B, Baron F, Beguin Y, Caers J.
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers. 2021; 13(12):3072.
https://doi.org/10.3390/cancers13123072
Chicago/Turabian Style
Lejeune, Margaux, Elodie Duray, Matthias Peipp, Béatrice Clémenceau, Frédéric Baron, Yves Beguin, and Jo Caers.
2021. "Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma" Cancers 13, no. 12: 3072.
https://doi.org/10.3390/cancers13123072
APA Style
Lejeune, M., Duray, E., Peipp, M., Clémenceau, B., Baron, F., Beguin, Y., & Caers, J.
(2021). Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers, 13(12), 3072.
https://doi.org/10.3390/cancers13123072